Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data
暂无分享,去创建一个
H. Birnbaum | M. Wintle | S. Emani | E. Wu | A. Oglesby | A. Yu | G. Pohl | E. Yang | M. Fay | Madeleine Fay
[1] V. Basevi. Standards of medical care in diabetes--2007. , 2009, Diabetes care.
[2] Judith Wylie-Rosett,et al. Nutrition Recommendations and Interventions for Diabetes , 2008, Diabetes Care.
[3] S. Grundy,et al. Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus , 2006, Diabetes Care.
[4] C. Apovian,et al. Nutrition Recommendations and Interventions for Diabetes–2006 , 2006, Diabetes Care.
[5] R. Eckel,et al. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. , 2006, Circulation.
[6] J H Pinkney,et al. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors , 2006, Postgraduate Medical Journal.
[7] N. Clark,et al. Standards of Medical Care in Diabetes: Response to Power , 2006 .
[8] Stephen W. Sorensen,et al. The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance , 2005, Annals of Internal Medicine.
[9] David B Allison,et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. , 2004, Circulation.
[10] Anirban Basu,et al. Comparing alternative models: log vs Cox proportional hazard? , 2004, Health economics.
[11] Mark R Conaway,et al. Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study. , 2004, Diabetes care.
[12] M. Engelgau,et al. The Evolving Diabetes Burden in the United States , 2004, Annals of Internal Medicine.
[13] V. Fonseca. Effect of thiazolidinediones on body weight in patients with diabetes mellitus. , 2003, The American journal of medicine.
[14] Arlene S Ash,et al. Using claims data to examine mortality trends following hospitalization for heart attack in Medicare. , 2003, Health services research.
[15] Morton B. Brown,et al. The direct medical cost of type 2 diabetes. , 2003, Diabetes care.
[16] Walter C Willett,et al. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. , 2003, JAMA.
[17] J. Chan,et al. Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin. , 2003, Mayo Clinic proceedings.
[18] P. Hogan,et al. Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.
[19] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.
[20] L. Annemans,et al. A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients. , 2002, Diabetes care.
[21] A. Gandjour,et al. Development process of an evidence-based guideline for the treatment of obesity. , 2001, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[22] H. Nawaz,et al. American College of Preventive Medicine Practice Policy statement. Weight management counseling of overweight adults. , 2001, American journal of preventive medicine.
[23] M. Thun,et al. Intentional Weight Loss and Mortality among Overweight Individuals with Diabetes O R I G I N a L a R T I C L E , 2022 .
[24] M. Engelgau,et al. Diabetes trends in the U.S.: 1990-1998. , 2000, Diabetes care.
[25] J. Halter,et al. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults , 2000, Journal of epidemiology and community health.
[26] D. Matthews,et al. Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude. , 2000, QJM : monthly journal of the Association of Physicians.
[27] G. Colditz,et al. The disease burden associated with overweight and obesity. , 1999, JAMA.
[28] W. Poston,et al. The challenge of diet, exercise and lifestyle modification in the management of the obese diabetic patient , 1999, International Journal of Obesity.
[29] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[30] Serrano Rios. Relationship between obesity and the increased risk of major complications in non‐insulin‐dependent diabetes mellitus , 1998, European journal of clinical investigation.
[31] Uk-Prospective-Diabetes-Study-Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.
[32] L. Simons,et al. Beneficial Effect on Average Lipid Levels From Energy Restriction and Fat Loss in Obese Individuals With or Without Type 2 Diabetes , 1998, Diabetes Care.
[33] R. J. Hayes,et al. United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet Therapy , 1998, Annals of Internal Medicine.
[34] D. Williamson,et al. Weight change and diabetes incidence: findings from a national cohort of US adults. , 1997, American journal of epidemiology.
[35] B. Zinman. Translating the Diabetes Control and Complications Trial (DCCT) into clinical practice: overcoming the barriers , 1997, Diabetologia.
[36] A. R. Frisancho. Physical Status: The Use and Interpretation of Anthropometry , 1996, The American Journal of Clinical Nutrition.
[37] F. Pi‐Sunyer,et al. Weight and non-insulin-dependent diabetes mellitus. , 1996, The American journal of clinical nutrition.
[38] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[39] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[40] G. Bray,et al. Treatment of obesity: an overview. , 1988, Diabetes/metabolism reviews.
[41] Simon Smyth,et al. Diabetes and obesity: the twin epidemics , 2006, Nature Medicine.
[42] B. Hoogwerf,et al. Nutrition principles and recommendations in diabetes. , 2004, Diabetes care.
[43] M K Campbell,et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. , 2004, Health technology assessment.
[44] A. Mokdad,et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.
[45] Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. , 2003, Diabetes care.
[46] B. Hoogwerf,et al. American Diabetes Association position statement: evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. , 2002, Journal of the American Dietetic Association.
[47] H. Birnbaum,et al. Productivity and medical costs of diabetes in a large employer population. , 2002, Diabetes care.
[48] R. Holman,et al. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51) , 2001, Diabetologia.
[49] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[50] S. Colagiuri,et al. The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.